Home » Topics » Regulatory » Patents

Patents
RSS

Palobiofarma describes adenosine A2B antagonists and melatonin MT3 receptor ligands

Sep. 12, 2016

Acesys Pharmatech discloses antibacterial agents

Sep. 12, 2016

Ligand Pharmaceuticals patents gemcitabine derivatives

Sep. 12, 2016

Curtana Pharmaceuticals describes new Oligo2 inhibitors

Sep. 9, 2016

Lycera presents novel Rho-associated protein kinase 2 inhibitors

Sep. 9, 2016

Nimbus Lakshmi presents novel TYK2 inhibitors

Sep. 9, 2016

University of Michigan discloses new bromodomain-containing protein 4 inhibitors

Sep. 9, 2016

Bristol-Myers Squibb, Universite de Montreal patent novel PAR4 antagonists

Sep. 9, 2016

Theravance Biopharma presents new neprilysin inhibitors

Sep. 8, 2016

Rigel, Bristol-Myers Squibb disclose TGF-beta receptor and/or myostatin inhibitors

Sep. 8, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...